Showing 391-400 of 18069 results for "".
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
https://reachmd.com/programs/diabetes-discourse/breaking-down-biosimilar-insulins-a-look-at-the-regulatory-process-and-impacts/16062/How might biosimilar insulins transform the way we prescribe treatment for our patients with type 1 and type 2 diabetes?Physiogenomics and Diabetes
https://reachmd.com/programs/clinicians-roundtable/physiogenomics-and-diabetes/1911/Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.When & How to Screen Patients for Diabetes
https://reachmd.com/programs/diabetes-discourse/when-how-to-screen-patients-for-diabetes/12380/How early should we start screening for diabetes, and what tools are available to us? Dr. John Buse answers this FAQ in honor of Diabetes Alert Day.Diabetes in Pregnancy--The Coming Storm
https://reachmd.com/programs/clinicians-roundtable/diabetes-in-pregnancy-the-coming-storm/1792/A storm is coming, but few have heard the forecast. The obesity epidemic in the United States in all age groups will lead to a huge increase in diabetes during pregnancy. Our guest today is Doctor Thomas Moore. He is Professor and Chairman of the Department of Reproductive Medicine, UniversitA Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness
https://reachmd.com/programs/diabetes-discourse/a-wake-up-call-to-diabetes-spreading-awareness-of-its-seriousness/12378/It can be tempting for patients to undermine the seriousness of diabetes, but Dr. John Buse explains why we need to set the record straight.I Just Received an Offer from a Private Equity Firm. What Should I Do Now?
https://modernaesthetics.com/topics/practice-development/i-just-received-an-offer-from-a-private-equity-firm-what-should-i-do-now/35206/Why you need a knowledgeable transaction advisor when considering a private equity deal.Midwest Lipid Association Conference Series I
https://reachmd.com/programs/lipid-luminations/midwest-lipid-association-conference-series-i/1927/Tune in to hear Dr. Larry Kaskel on site at the Lipid Conference. In this first of a two part series, Dr. Kaskel catches top thought leaders at the conference to get their candid remarks on important lipid topics. Brought to you by:Strategies for Addressing Diabetes Stigma and Discrimination
https://reachmd.com/programs/diabetes-discourse/strategies-for-addressing-diabetes-stigma-and-discrimination/16367/Tune in to learn about the stigma and discrimination patients with diabetes can face and how we as healthcare providers can reduce that burden.Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
https://reachmd.com/programs/focus-on-diabetes/inhaled-corticosteroids-and-the-risks-of-diabetes-onset-and-progression/6093/Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the divisioEvaluating Early Signs of Diabetes: A Look at Asymptomatic Patients
https://reachmd.com/programs/diabetes-discourse/evaluating-early-signs-of-diabetes-a-look-at-asymptomatic-patients/12587/How can approach identifying diabetes early if patients appear asymptomatic in the beginning?